Navigation Links
Glaucoma procedure now available at Mayo Clinic aims to prevent further eye damage
Date:6/25/2008

JACKSONVILLE - For the first time in Florida, patients with glaucoma have a new treatment option known as the Trabectome. The minimally invasive procedure, which is available at Mayo Clinic and takes about 20 minutes, is designed to decrease pressure within the eye and stabilize the vision.

"The goal of this procedure is to prevent further damage within the eye," says ophthalmologist Rajesh Shetty, M.D. He says that some patients have been able to reduce or eliminate use of daily eye drop medications that regulate intraocular pressure.

Glaucoma, the second leading cause of blindness, is a disease that causes irreversible damage to the optic nerve from increasing pressure within the eye. This occurs because the eye produces a clear fluid that does not drain adequately and raises the eye pressure. The first sign of glaucoma is a loss of peripheral vision that is usually not noticed by the patient until it affects the central vision. Unfortunately, vision lost to glaucoma can't be restored so treatment aims to reduce eye pressure to prevent further damage.

Traditionally, ophthalmologists first prescribe eye drops to reduce the eye pressure, and if that doesn't work, they can perform a laser procedure (trabeculoplasty) to the existing internal drainage canal around the base of the cornea. A more invasive treatment is trabeculectomy, a surgical technique to create a new drain for the eye.

The Trabectome procedure uses a small probe that opens the eye's drainage system through a tiny incision in the eye's cornea. "It removes a small portion of the eye's natural drainage system so that it functions better," says Dr. Shetty. He says it should be used when eye drops and laser trabeculoplasty fail to reduce pressure and before trabeculectomy is considered. "I see this as another rung in the ladder of treatment for glaucoma," he says.

So far, more than a dozen patients have had the procedure at Mayo Clinic in Florida, alth
'/>"/>

Contact: Cynthia Nelson
nelson.cynthia1@mayo.edu
904-953-2299
Mayo Clinic
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New Imaging Tool Can Spot Glaucoma Risk
2. Glaucoma report points to increased costs
3. Diabetes Seems to Heighten Glaucoma Risk
4. New Welsh Self-Test to Cure Glaucoma, the Leading Cause of Preventable Blindness
5. QLT initiates phase II study of punctal plug drug delivery system for glaucoma & ocular hypertension
6. Glaucoma May Boost Cardiovascular Death Risk in Blacks
7. Mayor Bloomberg Declares March 6, 2008 World Glaucoma Day in New York City
8. Dr. Welsh Self-Test Diagnoses Glaucoma, the Leading Cause of Preventable- Blindness
9. Upcoming meeting will explore new technologies for glaucoma clinical drug trials
10. January is National Glaucoma Awareness Month
11. Cost of glaucoma medications may impact treatment

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., , PRINCETON, NJ, Nov. 20 /PRNewswire-Firs...oday that a Special Meeting of Shareholders will b...f the Meeting is to consider approval of two speci... approve and authorize the sale of all or substant...on the terms provided for in the asset purchase ag...
(Date:11/20/2009)..., , WASHINGTON, Nov. 20 /PRNewswire-USN...ic Bishops urged the Senate to make essential chan...ce federal law on abortion funding and conscience ...are for immigrants and include strong provisions f...d the Senate health care bill an "enormous disappo...
(Date:11/20/2009)... Senators and Congressmen ...uble Over their Health Care Vote , ... -- Senators and congressmen running for re-electi...political guru Charlie Cook, may come to regret vo... care bill, according to a breaking Zogby Internat...
(Date:11/20/2009)..., , CHICAGO, Nov. 20 /PRNewswire-USNewswire/...ked the U.S. Food and Drug Administration (FDA) to...hitening chemicals. ,, Citing concern about th...nistered without the benefit of professional consu...on said that the application of chemically based t...
(Date:11/20/2009)..., , HAIFA, Israel, November 20 /PRNew... Corp. (CVSL.OB), http://www.CVSLMEDICAL.COM , a ...ry technology, today announced that,the company,s ...applications,in Europe, Canada and the Far East fo...wire" applicable for all angioplasty (PCTA) proced...
Breaking Medicine News(10 mins):Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2
...een awarded a record order worth over $1 million b...ers . This is the biggest ever order placed with a... The order follows a joint venture agreement betw...country. The ambitious venture aims to ach...
...ld Indian tradition, popular yoga guru Swami Ramde...revent it from being patented overseas. ...n (of yoga) in America, the Indian government and ...anity. Also yoga cannot be run like a company," he...
...ed as thrilling and relieving, after four tough y...nsation of 130, 000 US dollars. Ryszard Kolb...nsurer ,when they refused to pay him accident cove... The accident took place in 2002 when Kolbuc, ...
...who are trained in a new communication method call...amilies change lifestyle behaviors, according to ...agues conducted a nonrandomized clinical trial in ...nd Adolescent Medicine. "This is an excit...
...on why the human immune system isn't able to stop ...could pave the way for better treatment. ...rsity School of Medicine found that the immune cel...system. Without the ability to respond to interfer...
... 2 years, has come to its rightful end. Spanish do...2000 years in prison for knowingly infecting pati...ctor worked in the Valencia area of Spain during 1...ts of morphine, and them injecting the rest into p...
Other Medicine News:Health News:Talking With Families may Help Prevent Childhood Obesity 2Health News:Researchers Identify Immune Dysfunction in Melanoma Patients 2Health News:Researchers Identify Immune Dysfunction in Melanoma Patients 3Health News:Killer Anesthetist Sentenced To 1933 Years In Prison 2
(Date:11/20/2009)... In response to a recent...ntly available medications designed to treat and p...ute, an independent nonprofit organization, is off...r Prevention of Prostate Cancer for free downloa...article, " Drugs to Deter Some Cancers Are Not Tak...
(Date:11/19/2009)...swire-FirstCall/ -- BioCryst Pharmaceuticals, Inc.... public offering of 5,000,000 shares of its common...eeds of $48.75 million. All of the shares are bei...elf registration statement previously filed with t...as also granted the underwriters a 30-day option t...
(Date:11/19/2009)...-- Riverain Medical announced today that the compa...l imaging distributor Christie Group to offer Soft... CAD. The exclusive agreement will bring Dayton, O...ian market through Christie Group,s established an... Chest Imaging increases the clarity of digital ch...
Breaking Medicine Technology:ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2Go Go Goji 21 UNO 28R 29 Fall Menu Is Berry Delicious 60101 1Go Go Goji 21 UNO 28R 29 Fall Menu Is Berry Delicious 60101 2Go Go Goji 21 UNO 28R 29 Fall Menu Is Berry Delicious 60101 3Catheter Delivered Valve May Help People With Heart Defects Avoid Multiple Surgeries 60096 1Catheter Delivered Valve May Help People With Heart Defects Avoid Multiple Surgeries 60096 2Catheter Delivered Valve May Help People With Heart Defects Avoid Multiple Surgeries 60096 3Catheter Delivered Valve May Help People With Heart Defects Avoid Multiple Surgeries 60096 4Ziehm Imaging and BrainLAB Improve Trauma and Spine Surgery With X ray Based Navigation 14594 1Ziehm Imaging and BrainLAB Improve Trauma and Spine Surgery With X ray Based Navigation 14594 2Ziehm Imaging and BrainLAB Improve Trauma and Spine Surgery With X ray Based Navigation 14594 3Ziehm Imaging and BrainLAB Improve Trauma and Spine Surgery With X ray Based Navigation 14594 4Ziehm Imaging and BrainLAB Improve Trauma and Spine Surgery With X ray Based Navigation 14594 5
...21, 2007/PRNewswire-FirstCall/ -- Bristol-Myers,Sq...from study,ETV-079, which showed that treatment wi...l load reduction than adefovir at 48 weeks,-- a re...int) and,24. These data from an open-label, random...ronic hepatitis B e-antigen (HBeAg),positive patie...
...ability to limit inflammation in models of,arthrit...sented at,Digestive Disease Week -, WASHINGTON, Ma...ny Alimentary Health today announced results from ... activity of a natural,probiotic bacterial strain ...ntis 35624), in models of arthritis and,Salmonella...
Other Medicine Technology:Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 2Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 3Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 4Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 5Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 6New Data On the Probiotic Strain Bifantis Shows Anti-Inflammatory,Properties and Increased Health Benefits 2New Data On the Probiotic Strain Bifantis Shows Anti-Inflammatory,Properties and Increased Health Benefits 3
S.O.B Medium without Magnesium
S.O.C. Medium
rHead Radial Implant System
Swanson Titanium Radial Head Implants
Medicine Products: